Literature DB >> 19671584

AMPK and TNF-alpha at the crossroad of cell survival and death in ischaemic heart.

Wei Peng, Yan Zhang, Weizhong Zhu, Chun-Mei Cao, Rui-Ping Xiao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19671584      PMCID： PMC2741349          DOI： 10.1093/cvr/cvp272

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  18 in total

1.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

2.  Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

Authors:  D Bryant; L Becker; J Richardson; J Shelton; F Franco; R Peshock; M Thompson; B Giroir
Journal:  Circulation       Date:  1998-04-14       Impact factor: 29.690

3.  Effect of AMPK activation on muscle glucose metabolism in conscious rats.

Authors:  R Bergeron; R R Russell; L H Young; J M Ren; M Marcucci; A Lee; G I Shulman
Journal:  Am J Physiol       Date:  1999-05

Review 4.  AMP-activated protein kinase: a core signalling pathway in the heart.

Authors:  A S Kim; E J Miller; L H Young
Journal:  Acta Physiol (Oxf)       Date:  2009-02-23       Impact factor: 6.311

5.  Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells.

Authors:  Jin-Taek Hwang; Dae Young Kwon; Ock Jin Park; Myung Sunny Kim
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

6.  Tumor necrosis factor-alpha gene expression in the tissues of normal mice.

Authors:  J S Hunt; H L Chen; X L Hu; T Y Chen; D C Morrison
Journal:  Cytokine       Date:  1992-09       Impact factor: 3.861

7.  High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.

Authors:  N Kudo; A J Barr; R L Barr; S Desai; G D Lopaschuk
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

8.  AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death.

Authors:  Girish Kewalramani; Prasanth Puthanveetil; Fang Wang; Min Suk Kim; Sylvia Deppe; Ashraf Abrahani; Dan S Luciani; James D Johnson; Brian Rodrigues
Journal:  Cardiovasc Res       Date:  2009-05-28       Impact factor: 10.787

9.  Tumors secreting human TNF/cachectin induce cachexia in mice.

Authors:  A Oliff; D Defeo-Jones; M Boyer; D Martinez; D Kiefer; G Vuocolo; A Wolfe; S H Socher
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

10.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582
View more
  4 in total

Review 1.  Implications of Necroptosis for Cardiovascular Diseases.

Authors:  Zhao-Hui Ruan; Zi-Xuan Xu; Xue-Yun Zhou; Xian Zhang; Lei Shang
Journal:  Curr Med Sci       Date:  2019-07-25

2.  AMP-activated protein kinase α2 protects against liver injury from metastasized tumors via reduced glucose deprivation-induced oxidative stress.

Authors:  Shu-Lan Qiu; Zhi-Cheng Xiao; Chun-Mei Piao; Ying-Lin Xian; Li-Xin Jia; Yong-Fen Qi; Jia-Huai Han; You-Yi Zhang; Jie Du
Journal:  J Biol Chem       Date:  2014-02-10       Impact factor: 5.157

3.  AMP-activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress.

Authors:  Chi-Hsiao Yeh; Tzu-Ping Chen; Yao-Chang Wang; Yu-Min Lin; Shu-Wen Fang
Journal:  Mediators Inflamm       Date:  2011-01-23       Impact factor: 4.711

Review 4.  Natural AMPK Activators in Cardiovascular Disease Prevention.

Authors:  Reza Heidary Moghaddam; Zeinab Samimi; Sedigheh Asgary; Pantea Mohammadi; Soroush Hozeifi; Fatemeh Hoseinzadeh-Chahkandak; Suowen Xu; Mohammad Hosein Farzaei
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.